Advertisement

Topics

Search Results for "Galderma Company Rpofile"

03:17 EDT 26th September 2016 | BioPortfolio

Matching Channels

Medtronic

With annual sales reaching $15 billion in 2010, Medtronic is the 4th largest medical devices company in the world (based on annual sales). The device portfolio of Medtronic is broad; covering card...

The Top 100 Drugs

The pharmaceutical industry is massive, both in range of products and in financial values. These are the top 200 drugs (ranked in descending order according to total sales in 20010, $), and the co...

MediciGlobal is a specialty patient recruitment-retention organization serving the clinical trials industry

MediciGlobal is a specialty patient recruitment-retention organization serving the clinical trials industry. For more than two decades, the company has led the industry in developing innovative p...

Datamonitor - aims to help its clients operating in the pharmaceuticals, healthcare and biotechnology fields, offering world-leading products and services to meet the challenges of this rapidly evolving marketplace

The Datamonitor Group aims to help its clients operating in the pharmaceuticals, healthcare and biotechnology fields, offering world-leading products and services to meet the challenges of this rapi...

Rivaroxaban

Rivaroxaban is the most broadly indicated novel oral anticoagulant and is marketed under the brand name Xarelto®. To date, Xarelto has been approved for use in the following indications across t...

Matching News

Senior Vigilance Manager – Galderma

Galderma is a global company delivering innovative medical solutions to meet the dermatological needs of people throughout their lifetime.With more than 5,500 employees, Galderma has three units focus...

Galderma secures FDA approval for Differin Gel as OTC treatment for acne

Galderma's U.S. affiliate, Galderma Laboratories received approval from the U.S. Food and Drug Administration (FDA) for Differin Gel (adapalene gel 0.1%) as an over-the-counter (OTC) treatment for acn...

Galderma unveils a new look for Cetaphil line

One of Galderma's most popular skin care product lines is getting a full graphics and packaging upgrade. read more

Galderma licenses nemolizumab from Chugai

Chugai Pharmaceuticals and Switzerland’s Galderma have entered into a global license agreement for…

Galderma launches new Mirvaso Gel pump dispenser

David SalazarMirvaso was approved in 2013 as a first-in-class treatment for rosacea-related redness, and according to Galderma it can start working for some patients 30 minutes after application and l...

FDA Mulls Approach To Switches In Context Of Galderma's Acne Drug OTC Bid

FDA's OTC division uses the NDAC meeting on Galderma's Differin Gel switch proposal to ask for the advisory committee's input on evaluating future NDAs for other switches that could introduce new risk...

Chugai, Galderma sign license deal for skin disorder treatment

Chugai Pharmaceutical granted Galderma Pharma an exclusive worldwide license for CIM331, or nemolizumab, a humanized monoclon -More- 

Galderma licenses Chugai's atopic dermatitis candidate nemolizumab

Galderma SA licensed worldwide development and marketing rights (except in Japan and Taiwan) to Chugai Pharmaceutical Co. Ltd.'s dermatology candidate nemolizumab (CIM331).

Matching PubMed Articles

The History of Articulators: The Contributions of Rudolph L. Hanau and His Company-Part II.

This article is an historical overview of the Hanau Engineering Company from the time of Rudolph Hanau's death in 1930 to the present. It explores the development of many articulators intended both fo...

Strategies for Health System Innovation After Gobeille v Liberty Mutual Insurance Company.

Intergenerational Cycles of Trauma and Violence: An Attachment and Family Systems Perspectiveby Pamela C. Alexander; New York, W. W. Norton and Company, 2015, 370 pages.

A Quantitative Analysis of OnabotulinumtoxinA, AbobotulinumtoxinA, and IncobotulinumtoxinA: A Randomized, Double-Blind, Prospective Clinical Trial of Comparative Dynamic Strain Reduction.

U.S. Food and Drug Administration-approved formulations of botulinum toxin include onabotulinumtoxinA (Botox; Allergan, Inc., Irvine, Calif.), abobotulinumtoxinA (Dysport; Galderma Pharma S.A., Lausan...

Control of Ammonia and Urea Emissions from Urea Manufacturing Facilities of Petrochemical Industries Company (PIC) - Kuwait.

Petrochemical Industries Company (PIC) in Kuwait has mitigated the pollution problem of ammonia and urea dust by replacing the melting and prilling units of finished product urea prills with an enviro...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement